Litigation Details for Plaintiff(s) v. Defendant(s) (D. Del. 2020)
✉ Email this page to a colleague
Plaintiff(s) v. Defendant(s) (D. Del. 2020)
Small Molecule Drugs cited in Plaintiff(s) v. Defendant(s)
Biologic Drugs cited in Plaintiff(s) v. Defendant(s)
The biologic drugs covered by the patents cited in this case are ⤷ Sign Up , ⤷ Sign Up , ⤷ Sign Up , ⤷ Sign Up , ⤷ Sign Up , ⤷ Sign Up , and ⤷ Sign Up .
Details for Plaintiff(s) v. Defendant(s) (D. Del. 2020)
Date Filed | Document No. | Description | Snippet | Link To Document |
---|---|---|---|---|
0000-00-00 | External link to document | |||
2020-09-25 | 1071 | Complaint | ,839,637 (“the ’637 patent”) and 10,307,419 (“the ’419 patent”). {01611126;v1 } …the ’362 patent and U.S. Patent Nos. 8,349,840 (“the ’840 patent”), 8,618,109 (“the ’109 patent”), 9,839,637…civil action for patent infringement of U.S. Reissue Patent No. RE48,059 (“the RE’059 patent”), arising under…’362 patent as the RE’059 patent on June 23, 2020. A true and correct copy of the RE’059 patent is attached… The Patent In Suit 18. The United States Patent and Trademark Office ( | External link to document |
2020-09-25 | 1072 | Complaint | 9,839,637 (“the ’637 patent”) and 10,307,419 (“the ’419 patent”). 33. In response to Lupin…the ’362 patent and U.S. Patent Nos. 8,349,840 (“the ’840 patent”), 8,618,109 (“the ’109 patent”), 9,839,637…civil action for patent infringement of U.S. Reissue Patent No. RE48,059 (“the RE’059 patent”), arising under…’362 patent as the RE’059 patent on June 23, 2020. A true and correct copy of the RE’059 patent is attached… The Patent In Suit 25. The United States Patent and Trademark Office ( | External link to document |
2020-09-25 | 1073 | Complaint | 9,839,637 (“the ’637 patent”) and 10,307,419 (“the ’419 patent”). {01611225;v1 } …the ’362 patent and U.S. Patent Nos. 8,349,840 (“the ’840 patent”), 8,618,109 (“the ’109 patent”), 9,839,637…civil action for patent infringement of Reissue Patent No. RE48,059 (“the RE’059 patent”), arising under…’362 patent as the RE’059 patent on June 23, 2020. A true and correct copy of the RE’059 patent is attached… The Patent In Suit 36. The United States Patent and Trademark Office ( | External link to document |
2020-10-07 | 1131 | Complaint | United States Patent Nos. 10,617,698 (“the ’698 Patent”), 10,660,908 (“the ’908 Patent”), 10,682,364…10,682,364 (“the ’364 Patent”), 10,688,108 (“the ’108 Patent”), and 10,716,799 (“the ’799 Patent”) (collectively… This is a civil action for patent infringement arising under the patent laws of the United States, … This is a civil action for patent infringement arising under the patent laws of the United States, …are covered by claims of the Patents-in-Suit. 22. The Patents-in-Suit are listed in Approved | External link to document |
2020-10-08 | 1133 | Complaint | 9,763,886 (“the ‘886 patent”); 9,073,933 (“the ’933 patent”); 9,522,919 (“the ’919 patent”); and 10,407,434…RELIEF (PATENT INFRINGEMENT OF U.S. PATENT NO. 9,073,933) 58. Purdue…United States Patent Nos. 9,763,933 (“the Mannion ’933 patent”); 9,775,808 (“the ’808 patent”); 9,763,886…infringed the ’886 patent. Defendants have infringed the Orange Book patents and the ’886 patent at least under…1. This is an action for patent infringement arising under the patent laws of the United States, | External link to document |
2020-10-09 | 1140 | Complaint | Pharmaceuticals Limited’s Dapsone Gel, 7.5%; U.S. Patent Nos. 9,161,926 and 9,517,219” (the “Notice Letter”). …This is an action for patent infringement brought under the United States Patent Act and the Hatch-Waxman…the expiration of United States Patent No. 9,517,219 (“the ’219 Patent”), which covers, inter alia, the… THE PATENT-IN-SUIT 16. On December 13, 2016, the United States Patent and Trademark…before the ʼ219 Patent expires. CLAIM FOR INFRINGEMENT OF THE ’219 PATENT 28. | External link to document |
>Date Filed | >Document No. | >Description | >Snippet | >Link To Document |